Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

DEBORA A ORTEGA-CARR

Allopathic & Osteopathic Physicians Allergy & Immunology

NPI
1497725667
CMS profile
860800
Location
COLUMBUS, OH

General Payments · PY2018–2024

$3,209.53

  • Reported across 139 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$753.91

34 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $753.91 34

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Acerta Pharma LLC $243.00 8
Regeneron Healthcare Solutions, Inc. $136.85 7
PFIZER INC. $101.21 5
GlaxoSmithKline, LLC. $54.37 3
Kaleo, Inc. $51.28 3
Takeda Pharmaceuticals U.S.A., Inc. $48.47 2
GENZYME CORPORATION $39.48 2
CSL Behring $37.06 2
Amgen Inc. $22.22 1
Genentech USA, Inc. $19.97 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $78.77 5
PY2019 $146.57 10
PY2020 $111.80 7
PY2021 $301.45 13
PY2022 $742.62 28
PY2023 $1,074.41 42
PY2024 $753.91 34

Payment records · PY2024 (34)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Amgen Inc. $22.22 04/03/2024 Food and Beverage Undisputed 01/23/2026 1111666540 CMS
AstraZeneca Pharmaceuticals LP $133.47 01/17/2024 Food and Beverage Undisputed 01/23/2026 1105895420 CMS
AstraZeneca Pharmaceuticals LP $14.17 02/06/2024 Food and Beverage Undisputed 01/23/2026 1104458314 CMS
AstraZeneca Pharmaceuticals LP $17.41 02/07/2024 Food and Beverage Undisputed 01/23/2026 1105871547 CMS
AstraZeneca Pharmaceuticals LP $14.96 02/29/2024 Food and Beverage Undisputed 01/23/2026 1104580028 CMS
AstraZeneca Pharmaceuticals LP $13.76 04/10/2024 Food and Beverage Undisputed 01/23/2026 1105257425 CMS
AstraZeneca Pharmaceuticals LP $19.66 05/22/2024 Food and Beverage Undisputed 01/23/2026 1104370865 CMS
AstraZeneca Pharmaceuticals LP $14.31 11/20/2024 Food and Beverage Undisputed 01/23/2026 1105499952 CMS
AstraZeneca Pharmaceuticals LP $15.26 12/04/2024 Food and Beverage Undisputed 01/23/2026 1105571047 CMS
CSL Behring $19.76 01/10/2024 Food and Beverage Undisputed 01/23/2026 1134643131 CMS
CSL Behring $17.30 06/26/2024 Food and Beverage Undisputed 01/23/2026 1134643195 CMS
Genentech USA, Inc. $19.97 07/10/2024 Food and Beverage Undisputed 01/23/2026 1133000070 CMS
GENZYME CORPORATION $17.70 02/14/2024 Food and Beverage Undisputed 01/23/2026 1139609682 CMS
GENZYME CORPORATION $21.78 02/26/2024 Food and Beverage Undisputed 01/23/2026 1139609686 CMS
GlaxoSmithKline, LLC. $14.56 05/22/2024 Food and Beverage Undisputed 01/23/2026 1116296947 CMS
GlaxoSmithKline, LLC. $21.58 08/21/2024 Food and Beverage Undisputed 01/23/2026 1116269899 CMS
GlaxoSmithKline, LLC. $18.23 09/04/2024 Food and Beverage Undisputed 01/23/2026 1116551395 CMS
kaleo, Inc. $20.22 02/21/2024 Food and Beverage Undisputed 01/23/2026 1126623998 CMS
kaleo, Inc. $16.96 04/17/2024 Food and Beverage Undisputed 01/23/2026 1126624002 CMS
kaleo, Inc. $14.10 04/24/2024 Food and Beverage Undisputed 01/23/2026 1126624000 CMS
PFIZER INC. $17.07 01/25/2024 Food and Beverage Undisputed 01/23/2026 1130982295 CMS
PFIZER INC. $16.75 03/22/2024 Food and Beverage Undisputed 01/23/2026 1131053374 CMS
PFIZER INC. $22.16 06/18/2024 Food and Beverage Undisputed 01/23/2026 1131681805 CMS
PFIZER INC. $21.26 10/16/2024 Food and Beverage Undisputed 01/23/2026 1130890437 CMS
PFIZER INC. $23.97 10/28/2024 Food and Beverage Undisputed 01/23/2026 1131100353 CMS
Regeneron Healthcare Solutions, Inc. $30.00 04/09/2024 Food and Beverage Undisputed 01/23/2026 1114128250 CMS
Regeneron Healthcare Solutions, Inc. $16.25 08/14/2024 Food and Beverage Undisputed 01/23/2026 1114128252 CMS
Regeneron Healthcare Solutions, Inc. $3.50 08/14/2024 Food and Beverage Undisputed 01/23/2026 1114128254 CMS
Regeneron Healthcare Solutions, Inc. $20.93 09/17/2024 Food and Beverage Undisputed 01/23/2026 1114128256 CMS
Regeneron Healthcare Solutions, Inc. $29.29 09/24/2024 Food and Beverage Undisputed 01/23/2026 1114128258 CMS
Regeneron Healthcare Solutions, Inc. $31.40 11/21/2024 Food and Beverage Undisputed 01/23/2026 1114128260 CMS
Regeneron Healthcare Solutions, Inc. $5.48 11/26/2024 Food and Beverage Undisputed 01/23/2026 1114128262 CMS
Takeda Pharmaceuticals U.S.A., Inc. $27.90 03/26/2024 Food and Beverage Undisputed 01/23/2026 1137646604 CMS
Takeda Pharmaceuticals U.S.A., Inc. $20.57 08/27/2024 Food and Beverage Undisputed 01/23/2026 1137646606 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.